Sphingotec GmbH Stock

SphingoTec develops innovative biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions.

Sign up today and learn more about Sphingotec GmbH Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Sphingotec GmbH Stock

SphingoTec is a biomaker company that develops and markets in vitro diagnostic solutions for novel and proprietary blood-based protein biomarkers. They also develop microtiter plates, which are a standard tool in analytical research and diagnostic testing laboratories. They develop biomakers to address diagnostically underserved critical care conditions such as acute kidney injury, sepsis, and acute heart failure.

Funding History

March 2023$1.5M

Management

CEO

Jörg Menten

Founder & CSO

Andreas Bergmann

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo